Αντιπροσωπευτικές Επιστημονικές δημοσιεύσεις

  1. Sypsa V et al. Effects of Social Distancing Measures during the First Epidemic Wave of Severe Acute Respiratory Syndrome Infection, Greece. Emerg Infect Dis. 2021 Feb; 27(2): 452–462.
  2. Bowman B et al. Sexual Mixing and HIV Transmission Potential Among Greek Men Who have Sex with Men: Results from SOPHOCLES. AIDS Behav.2021; 25(6): 1935–1945.
  3. Sypsa V et al.  Food insecurity among people who inject drugs in Athens, Greece: a study in the context of ARISTOTLE programme. 2021. Public Health Nutr.2021 Apr 24(5): 813–818.
  4. Psichogiou M et al. Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19. PLoS One.2020; 15(12).
  5. Pavlopoulou I et al. High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece. BMC Public Health. 2020 Jan 20(1):105.
  6. Fountains Il et al. A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study. J Viral Hepat. 2019 Nov;26(11):1311-1317.
  7. Gountas Il et al. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. World J Gastroenterol.2019 Mar 21; 25(11): 1327–1340.
  8. Kostaki EG et al. Near Full-length Genomic Sequencing and Molecular Analysis of HIVInfected Individuals in a Network-based Intervention (TRIP) in Athens, Greece: Evidence that Transmissions Occur More Frequently from those with High HIV-RNA. Current HIV Research. 2018, 16.
  9. Paraskevis D et al. Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011–2014) in Athens, Greece. Infection, Genetics and Evolution. 2018, 62.
  10. Williams L et al. Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece. Frontiers in Microbiology. 2018, 9.
  11. Kostaki EG et al. Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach. 2018, 7.
  12. Paraskevis D et al. Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens. Clinical Infectious Disease. 2017, 65.
  13. Paraskevis D et al. Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens. Clinical Infectious Disease. 2017, 65.
  14. Sypsa V et al. Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens. The Journal of Infectious Disease. 2017, 215.
  15. Tsang MA et al. Network characteristics of people who inject drugs within a new HIV epidemic following austerity in Athens, Greece. 2015, 69.
  16. Hatzakis A et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015, 110.
  17. Nikolopoulos GK et al. National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: a panel data analysis. PLoS One. 2015, 10.
  18. Syspa V et al. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. American Journal of Public Health. 2015, 105.
  19. Friedman SR et al. Socially-integrated transdisciplinary HIV prevention. AIDS and Behavior. 2014, 10.
  20. Paraskevis D et al. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology. 2013, 57, 3.
  21. Katsoulidou A et al. Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D. Journal of Viral Hepatitis. 2013, 20.
  22. Ntziora F et al. Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine. Journal of Clinical Microbiology. 2013, 9.
  23. Magiorkinis G et al. Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLOS Computational Biology. 2013, 9.
  24. Beloukas A et al. Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships. Virus Research. 2012, 166:54.
  25. Zavitsanou M et al. Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users. Epidemiology and Infection. 2011, 138, 3.
  26. Katsoulidou A et al. Comparative evolution of the performance of the Abbott Real Time HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virology Journal. 2011, 8:10.
  27. Paraskevis D et al. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology. 2009, 6, 49.
  28. Nikolopoulos G et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clinical Infectious Diseases.  2009, 48.
  29. Magiorkinis G et al. The global spread of hepatitis V virus 1a and 1b: a phylodynamic and phylogeographic analysis.  Plos Medicine.  2009, 6, 12. (Academy of Athens Special Award, December 29/2011)
  30. Ntziora F et al. Quantitative detection of M204V hepatitis B virus minor variants by amplification refractory mutation system Real-Time PCR combined with molecular beacon technology. Journal of Clinical Microbiology. 2009, 47, 8.
  31. Katsoulidou A et al. Molecular characterization of occult hepatitis B cases in Greek blood donors. Journal of Medical Virology. 2009, 81.
  32. Kantzanou M et al. Searching for West Nile Virus (WNV) in Greece. Transfusion Medicine. 2009, 19.
  33. Papachristou E et al. Prevalence of different HPV types and estimation of prognostic risk factors based on the linear arraary HPV genotyping test. Journal of Medical Virology. 2009, 81.
  34. Magiorkinis E et al. Emergence of and NNRTI resistance mutation Y181C in an HIV-infected NNRTI-Naïve patient. AIDS Research and Human Retroviruses. 2008, 24, 3, 413-415.
  35. Magiorkinis G et al. Analyzing the evolutionary history of HCV: puzzle of ancient phylogenetic discordance. Infection, Genetics and Evolution. 2007, 7, 354-360.
  36. Paraskevis D et al. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. Journal of Infectious Diseases. 2007, 196, 1167-1176.
  37. Magiorkinis E et al. Re-analysis of a human hepatitis B virus (HBV) isolate from an East African wild born Pan troglodytes schweinfurthii: evidence for interspecies recombination between HBV infecting chimpanzee and human.  2005, 349, 165-171.
  38. Paraskevis D et al. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Research. 2005, 112, 115-122.
  39. Paraskevis D et al. Phylogenetic reconstruction of a known HIV-1 CRF04_cpx transmission network using maximum likelihood and Bayesian methods.  Journal of Molecular Evolution. 2004, 59, 709-717.
  40. Paraskevis D et al. Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. Journal of General Virology. 2001, 82, 2509-2514.